Hopkinton Drug, Inc.
FDA inspection history in Hopkinton, Massachusetts, 2020 to 2021
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2020: one Form 483; 2021: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2020–21One Form 483 and one warning letter, at Hopkinton, Massachusetts.
Cited most
Across all Hopkinton Drug observations on file
- 21 CFR 211.67Equipment cleaning and maintenance2
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.56Sanitation1
The complete Hopkinton Drug file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Hopkinton, Massachusetts
One warning letter and one Form 483 · 2020 to 2021 · 2 observations
Latest: Warning letter, Sep 16, 2021 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-09-16 | Warning letter Warning letter | Hopkinton, Massachusetts | — | $99 |
| 2020-11-02 | 483 Form 483 | Hopkinton, Massachusetts | 2 | $99 |
Investigators on these documents
Daniel L. Zheng (1)Erik W. Koester (1)Jonathan G. Matrisciano (1)
FEI number 3005543749 · most recent document Sep 16, 2021
About Hopkinton Drug, Inc.
How many FDA Form 483s has Hopkinton Drug, Inc. received?
FDA Intel has 1 Form 483 on file for Hopkinton Drug, Inc.; the most recent is dated Nov 2, 2020.
When was Hopkinton Drug, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Hopkinton Drug, Inc. is a Form 483 dated Nov 2, 2020, for the site in Hopkinton, Massachusetts.
What did FDA cite at Hopkinton Drug, Inc.?
The regulations cited most in the observations on file for Hopkinton Drug, Inc. are 21 CFR 211.67 (Equipment cleaning and maintenance), 2 times; 21 CFR 211.42 (Design and construction features), 1 time; 21 CFR 211.56 (Sanitation), 1 time.
Has Hopkinton Drug, Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Hopkinton Drug, Inc.; the most recent is dated Sep 16, 2021.